Stephen A Harrison (Stephen Harrison)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Ankylosing Spondylitis

Rheumatoid Arthritis Patients

Top Venues

Nature medicine

Hepatology (Baltimore, Md.)

Liver international : official journal of the International Association for the Study of the Liver

Postgraduate medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Faiez Zannad, Arun J Sanyal, Javed Butler, Veronica Miller, Stephen A Harrison
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease. Nature medicine (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2024)
Stephen A Harrison, Rebecca Taub, Guy W Neff, K Jean Lucas, Dominic Labriola, Sam E Moussa, Naim Alkhouri, Mustafa R Bashir
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nature medicine (2023)
Stephen A Harrison, Alina M Allen, Julie Dubourg, Mazen Noureddin, Naim Alkhouri
Challenges and opportunities in NASH drug development. Nature medicine 29 (3) (2023)
Stephen A Harrison, Alina M Allen, Julie Dubourg, Mazen Noureddin, Naim Alkhouri
Challenges and opportunities in NASH drug development. Nature medicine 29 (3) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Stephen A Harrison, Alina M Allen, Julie Dubourg, Mazen Noureddin, Naim Alkhouri
Challenges and opportunities in NASH drug development. Nature medicine (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Melissa Palmer, David E Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I Avigan, Arie Regev, Paul H Hayashi, James H Lewis, Ruby Mehta, Stephen A Harrison, Massimo Siciliano, Charles A McWherter, Raj K Vuppalanchi, Cynthia Behling, Veronica Miller, Naga P Chalasani, Arun J Sanyal
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum. Alimentary pharmacology & therapeutics (2023)
Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harrison, Paul J Thuluvath, Aparna Goel, Mitchell L Shiffman, Mark G Swain, David E J Jones, Palak J Trivedi, Andreas E Kremer, Richard J Aspinall, David A Sheridan, Yvonne Dörffel, Ke Yang, Yun-Jung Choi, Charles A McWherter
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis. Alimentary pharmacology & therapeutics (2023)
Stephen A Harrison, Julie Dubourg
Editorial: Liver hypercortisolism as a potential target for MASH treatment. Alimentary pharmacology & therapeutics 58 (11-12) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) (2023)
Stephen A Harrison, Federico Perez Manghi, William B Smith, Diana Alpenidze, Diego Aizenberg, Naomi Klarenbeek, Chi-Yi Chen, Eli Zuckerman, Eric Ravussin, Phunchai Charatcharoenwitthaya, Pin-Nan Cheng, Helena Katchman, Samuel Klein, Ziv Ben-Ari, Anisha E Mendonza, Yiming Zhang, Miljen Martic, Shenglin Ma, Sheena Kao, Sandra Tanner, Alok Pachori, Michael K Badman, YanLing He, Chinweike Ukomadu, Eric Sicard
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study. Nature medicine 28 (7) (2022)
Stephen A Harrison, Patrick R Mayo, Todd M Hobbs, Carlos Canizares, Erin P Foster, Caroline Zhao, Daren R Ure, Daniel J Trepanier, Jill A Greytok, Robert T Foster
Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH. Hepatology communications 6 (12) (2022)
Francesco Rubino, Silvia Sabatini, Fabrizia Carli, Melania Gaggini, Fernando Bril, Renata Belfort-DeAguiar, Vincenzo Positano, Diana Barb, Sushma Kadiyala, Stephen A Harrison, Kenneth Cusi
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)